IP Library › Granted Patent US 8,153,614
Granted Patent B2
US 8,153,614 · App. 12/162,415 · Granted Apr 10, 2012

Treatment of osteoarthritis

Assignees: Glycoscience Laboratories, Inc.; Shiseido Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,153,614
App. No.
12/162,415
Granted
Apr 10, 2012
Kind
B2
Abstract

There is provided a therapeutic agent for treating osteoarthritis, which is a drug comprising hyaluronan as an active ingredient. The hyaluronan is preferably a tetrasaccharide including two units, with a single unit being -D-glucuronic acid-β-1,3-D-N-acetylglucosamine-β-1,4- (HA4).

Claims (3)

1. A method for treating osteoarthritis comprising a step of administering an effective amount of hyaluronan to a subject in need of such treatment, wherein the hyaluronan is a tetrasaccharide containing two units, with a single unit being -D-glucuronic acid-β-1,3-D-N-acetylglucosamine-β-1,4- and wherein the hyaluronan is orally administered.

2. The method according to claim 1 , wherein the hyaluronan is orally administered daily.

3. The method according to claim 2 , wherein the hyaluronan is orally administered daily in an amount between about 0.05 to about 50 mg/kg.

Assignments (2)
ASSIGNOR HAS SOLD AND BY THESE PRESENTS DOES HEREBY SELL, ASSIGN, TRANSFER, AND CONVEY UNTO THE SAID ASSIGNEE, ITS SUCCESSORS AND ASSIGNS, CERTAIN RIGHTS OF THE ENTIRE RIGHT, TITLE, AND INTEREST IN AND TO THE SAID INVENTION AND APPLICATION, Recorded Mar 15, 2010
From: GLYCOSCIENCE LABORATORIES, INC.
To: SHISEIDO CO., LTD.
Reel/Frame 024077/0161 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2008
From: ASARI, AKIRA
To: GLYCOSCIENCE LABORATORIES,INC.
Reel/Frame 021302/0043 →
Continuity (1)
Related Publication 20100234322A1 · Sep 16, 2010